Who's Who at GeneDB

Grant holders


Dr. Matt Berriman

The Wellcome Trust Sanger Institute [1]


Prof. David Roos

University of Pennsylvania [2]


Prof. Deborah Smith

University of York [3]


Dr. Mark Carrington

University of Cambridge [4]


Curators


Trypanosoma species:

Dr. Flora Logan-Klumpler currently on maternity leave

University of Cambridge, The Wellcome Trust Sanger Institute

Flora completed her Ph.D. in trypanosome vitamin C biosynthesis in Prof. John Kelly's group at the London School of Hygiene and Tropical Medicine in 2008. She then moved to the University of Georgia, Athens to work on Trypanosoma cruzi fatty acid metabolism, and T. cruzi specific ontology development in the Tarleton Research Group. She is now working on the curation and functional annotation of the Trypanosoma brucei genome and the development of a new phenotype curation tool utilising new and existing ontologies at WTSI. She is also involved in the Trypanocyc community annotation project.


Plasmodium species:

Dr. Ulrike Böhme

The Wellcome Trust Sanger Institute

Ulrike is curating and reannotating the Plasmodium falciparum genome database at WTSI, and has been involved in the analysis of a diverse collection of eukaryotic pathogens, including Toxoplasma gondii , Plasmodium knowlesi , and Plasmodium chabaudi .


Developers


Dr. Jacqueline McQuillan

The Wellcome Trust Sanger Institute

Jacqueline McQuillan has PhD is Software Engineering and joined the Pathogen Genomics group at the Wellcome Trust Sanger Institute as a postdoctoral fellow in 2008. In 2010, she took on the role of managing the Pathogen Informatics team whose main responsibilities are to develop sequence analysis pipelines and provide informatics support to the Pathogen Genomics group.


Dr. Andrew Page

The Wellcome Trust Sanger Institute

Andrew has a PhD in Computer Science in the area of distributed computing. He joined the Sequencing Informatics team at the Wellcome Trust Sanger Institute in 2009 as a Senior Software Developer and moved to the Pathogen Informatics team in June 2011 as a Principal Software Developer.


Dr. Craig Porter

The Wellcome Trust Sanger Institute

Craig has a PhD in Chemistry and an MSc in Information Technology. After several postdocs at UCL and the EBI, he joined the Pathogen Informatics group in November 2010 where he works as a Senior Bioinformatician.


Martin Aslett

The Wellcome Trust Sanger Institute

Martin trained originally as a zoologist at Leeds University, moving into Bioinformatics via a Masters degree at York University. Following this, he worked for 2 years in the Department of Pathology at the University of Cambridge before a spell as a visiting worker (employed by Edinburgh University) at the European Bioinformatics Institute. Martin then moved across the Wellcome Trust Genome Campus to the WTSI Pathogen Genomics informatics team, where he currently has a role providing informatics support to the wider Pathogen Genomics group.


Dr. Nishadi De Silva currently on maternity leave

The Wellcome Trust Sanger Institute

Nishadi completed her PhD in Computer Science at the University of Southampton. After two years of postdoctoral research in the Dependable Systems and Software Engineering group at the University of Southampton, she joined the Wellcome Trust Sanger Institute in April 2009 where she works in the Pathogen Genomics Informatics team.


Dr. Tim Carver

The Wellcome Trust Sanger Institute

Tim has a PhD in Chemistry. He did a postdoc at the University of Cambridge before joining the Medical Research Council in 2000. From 2004 he has been the lead developer for Artemis and ACT.


Past contributors


Dr. Christiane Hertz-Fowler

University of Liverpool

Dr. Christopher Peacock

University of Western Australia

Dr. Valerie Wood

University of Cambridge

Dr. Gary Dillon

Dr. Adrian Tivey

The Wellcome Trust Sanger Institute

Larry Oke

Dr. Robin Houston

Raeece Naeem

The Wellcome Trust Sanger Institute

Raeece is a computer science engineering graduate from India, and had worked for several commercial software development companies like TATA consultancy services. He moved to the Pathogens group in May 2009. Raeece plans to start his role as a Research engineer at the computational bioscience research center at KAUST Saudi Arabia in March 2011.

Kim Rutherford

University of Cambridge

Chinmay Patel

Dr. Matt Rogers

University of Pittsburgh

Matt obtained his Ph.D. in Botany from the University of British Columbia in 2006 in Prof. Patrick Keeling's lab. He then relocated to the UK where he joined Dr. Mark van der Giezen as a Wellcome Trust post-doctoral fellow at Queen Mary, University of London and the University of Exeter. His work at the WTSI was focused on functional annotation of Leishmania genomes and assembly and annotation of the Leishmania mexicana genome. He is also interested in evolutionary protistology, gene family evolution, lateral gene transfer, and strong coffee.

Dr. Tina Eyre

The Wellcome Trust Sanger Institute

Dr. Giles Velarde

University of Cambridge, University of York, The Wellcome Trust Sanger Institute

Giles trained originally as a biochemist at Manchester University, but over the course of his Ph.D. at UMIST, moved into bioinformatics and software engineering. Following his doctoral studies, he worked at the Sequence Analysis Group at Manchester Bioinformatics, followed by six years as part of the Bioanalytical Sciences Group at the Manchester Interdisciplinary Biocentre. As part of the WTSI Pathogen Genomics informatics team, he focused on the development of new tools for GeneDB and was the main developer of the CRAWL web-services for GeneDB.

About GeneDB

The GeneDB project is a core part of the Sanger Institute's Pathogen Genomics activities. Its primary goals are:


» to provide reliable access to the latest sequence data and annotation/curation for the whole range of organisms sequenced by the Pathogen group.
» to develop the website and other tools to aid the community in accessing and obtaining the maximum value from these data.


GeneDB currently provides access to more than 40 genomes, at various stages of completion, from early access to partial genomes with automatic annotation through to complete genomes with extensive manual curation.